Tissue Plasminogen Activator Induced Delayed Edema in Experimental Porcine Intracranial Hemorrhage: Reduction with Plasminogen Activator Inhibitor-1 Administration
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1868-601X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Tissue Plasminogen Activator Induced Delayed Edema in Experimental Porcine Intracranial Hemorrhage: Reduction with Plasminogen Activator Inhibitor-1 Administration ; volume:3 ; number:1 ; day:26 ; month:5 ; year:2012 ; pages:88-93 ; date:7.2012
Translational stroke research ; 3, Heft 1 (26.5.2012), 88-93, 7.2012
- Urheber
-
Keric, Naureen
Maier, Gerrit Steffen
Samadani, Uzma
Kallenberg, Kai
Dechent, Peter
Brueck, Wolfgang
Heuer, Jan
Rohde, Veit
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12975-012-0188-3
- URN
-
urn:nbn:de:101:1-2021080707473008744709
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Keric, Naureen
- Maier, Gerrit Steffen
- Samadani, Uzma
- Kallenberg, Kai
- Dechent, Peter
- Brueck, Wolfgang
- Heuer, Jan
- Rohde, Veit
- SpringerLink (Online service)
Ähnliche Objekte (12)
Die Bedeutung der Plasminogenaktivatoren tissue-type-plasminogen activator und urokinase-type plasminogen activator für den Ischämie-Reperfusionsschaden
Bone Marrow Plasminogen Activator in Malignant Disease
Relationship between serum and tear levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in diabetic retinopathy
Urokinase-type plasminogen activator receptor in vascular calcification
Influence of delivery on plasminogen activator inhibitor activity
Plasminogen Activator Release by Oral Contraceptives and Exercise
Isolation and Properties of Human Vascular Plasminogen Activator
Purification and Some Properties of Tissue Plasminogen Activator
Clinical Outcomes of Endovascular Thrombectomy in Tissue Plasminogen Activator versus Non-Tissue Plasminogen Activator Patients at Primary Stroke Care Centers
Analysis of Urokinase-type Plasminogen Activator (uPA), Plasminogen Activator Inhibitor Type-1 (PAI-1), and Urokinase Plasminogen Activator Receptor (uPAR) Protein Expression by Immunohistochemistry in Triple-Negative Breast Cancer (TNBC)
Quantification of urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) mRNA in breast cancer tissue
Uncharged isocoumarin-based inhibitors of urokinase-type plasminogen activator
Die Bedeutung der Plasminogenaktivatoren tissue-type-plasminogen activator und urokinase-type plasminogen activator für den Ischämie-Reperfusionsschaden
Bone Marrow Plasminogen Activator in Malignant Disease
Relationship between serum and tear levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in diabetic retinopathy
Urokinase-type plasminogen activator receptor in vascular calcification
Influence of delivery on plasminogen activator inhibitor activity
Plasminogen Activator Release by Oral Contraceptives and Exercise
Isolation and Properties of Human Vascular Plasminogen Activator
Purification and Some Properties of Tissue Plasminogen Activator
Clinical Outcomes of Endovascular Thrombectomy in Tissue Plasminogen Activator versus Non-Tissue Plasminogen Activator Patients at Primary Stroke Care Centers
Analysis of Urokinase-type Plasminogen Activator (uPA), Plasminogen Activator Inhibitor Type-1 (PAI-1), and Urokinase Plasminogen Activator Receptor (uPAR) Protein Expression by Immunohistochemistry in Triple-Negative Breast Cancer (TNBC)
Quantification of urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) mRNA in breast cancer tissue
Uncharged isocoumarin-based inhibitors of urokinase-type plasminogen activator
Die Bedeutung der Plasminogenaktivatoren tissue-type-plasminogen activator und urokinase-type plasminogen activator für den Ischämie-Reperfusionsschaden
Bone Marrow Plasminogen Activator in Malignant Disease
Relationship between serum and tear levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in diabetic retinopathy
Urokinase-type plasminogen activator receptor in vascular calcification
Influence of delivery on plasminogen activator inhibitor activity
Plasminogen Activator Release by Oral Contraceptives and Exercise
Isolation and Properties of Human Vascular Plasminogen Activator
Purification and Some Properties of Tissue Plasminogen Activator
Clinical Outcomes of Endovascular Thrombectomy in Tissue Plasminogen Activator versus Non-Tissue Plasminogen Activator Patients at Primary Stroke Care Centers
Analysis of Urokinase-type Plasminogen Activator (uPA), Plasminogen Activator Inhibitor Type-1 (PAI-1), and Urokinase Plasminogen Activator Receptor (uPAR) Protein Expression by Immunohistochemistry in Triple-Negative Breast Cancer (TNBC)
Quantification of urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) mRNA in breast cancer tissue